Claris Bio's journey toward treating neurotrophic keratitis

Season 2, Episode 38,   Apr 25, 2024, 05:34 PM

Headliner
Share
Subscribe
Claris CEO, Clarke Atwell, gives an update on the company and their path toward developing treatment for neurotrophic keratitis
Share
Subscribe
Next
Assessing the Evidence for Extending Treatment Intervals in nAMD & DME Management: Expert Insights into Innovative Approaches
Top episodes
What patients need to know about cataract surgery
by EyePod
Highlighting results from first FDA-reported study for treatment of presbyopia
by EyePod
Modifier Gene Therapy: What is it?
by EyePod